Guidance for patient involvement in regulatory processes
Free
EUPATI has developed these guidance documents for all stakeholders aiming to interact with patients on medicines research and development (R&D). Users may deviate from this guidance according to specific circumstances, national legislation or the unique needs of each interaction. This guidance should be adapted for individual requirements using best professional judgment.
Owner (organization)
Target audience
Regulators, Health Technology Assessment (HTA) bodies, Other, Consumers
Types
Guidance
Formats
Online e-learning
Levels
Unknown
Language
English
Accessibility
Not applicable
Certification
No
Patients involved
No
PFMD last access
28 Nov 2020
Organizations
